SMARCA4 and cardiac hypertrophy: In conclusion, the T3-dependent regulation of the Mhrt/Brg1 axis appears to be a novel cardioprotective mechanism that contributes to explain why TH treatment is associated with the reversal of pathological cardiac hypertrophy in favor of more physiological cardiac growth [10].